Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation

Movement Disorders

Volumn 28, Issue 12, 2013, Pages 1683-1690

  Mirelman, Anat ^a,b   Heman, Talia ^a   Yasinovsky, Kira ^a   Thaler, Avner ^a   Gurevich, Tanya ^a,c   Marder, Karen ^d   Bressman, Susan ^e   Bar Shira, Anat ^a   Orr Urtreger, Avi ^a,c   Giladi, Nir ^a,c   Hausdorff, Jeffrey M ^a,c,f   Saunders Pullman, Rachel ^e   Shanker, Vicki Lynn ^e   Groves, Mark ^e   Palmese, Christine ^e   Stanley, Kaili Maloy ^e   Iyer, Akhila ^e   Soto Valencia, Jeannie ^e   Raymond, Deborah ^e   Luciano, Marta San ^e   Deik, Andres ^e   Barrette, Matthew James ^e   Cabbasa, Jose ^e   Severt, Lawrence ^e   Hunt, Ann ^e   Lubarr, Naomi ^e   Sachdev, Rivka ^e   Lewis, Sara ^e   Ozelius, Laurie ^e   Alcalay, Roy ^g   Fahn, Stanley ^g   Cote, Lucien ^g   Greene, Paul ^g   Waters, Cheryl ^g   Mazzoni, Pietro ^g   Ford, Blair ^g   Louis, Elan ^g   Levy, Oren ^g   Tang, Ming Xin ^g   Rakitin, Brian ^g   Mejia, Helen ^g   Roos, Ernest ^g   Riley, Martha Orbe ^g   Rosado, Llency ^g   Moskowitz, Carol ^g   Dorovski, Tsvyatko ^g   Clark, Lorraine ^g   Liu, Xinmin ^g   Kisselev, Sergey ^g   Peer, Itsik ^g   Vacic, Vladimir ^g   Balash, Yaacov ^a   Hertzel, Shabtai ^a   Or, Ziv Gan ^a   Shira, Anat Bar ^a   Weiss, Mali Gana ^a   Kobo, Hila ^a   Bregman, Noa ^a   Kestenbaum, Meir ^a   Hendler, Talma ^a   Lehrman, Hedva ^a   Sapir, Einat Even ^a   Levy, Shiran ^a   Shkedy, Anat ^a   Zelis, Maayan ^a   more..

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d College of Physicians and Surgeons ^*  (United States)

^e BETH ISRAEL MEDICAL CENTER   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Falls; G2019S; Gait; LRRK2; Parkinson's disease

Indexed keywords

AMINO ACID; GLYCINE; LEUCINE RICH REPEAT KINASE 2; SERINE;

ACCELEROMETER; ADULT; ARTICLE; BODY POSTURE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FALLING; FEMALE; GAIT DISORDER; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TASK PERFORMANCE; UNIFIED PARKINSON DISEASE RATING SCALE; WALKING;

FALLS; G2019S; GAIT; LRRK2; PARKINSON'S DISEASE;

ACCIDENTAL FALLS; AGED; FEMALE; GAIT; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PHENOTYPE; POSTURAL BALANCE; PROTEIN-SERINE-THREONINE KINASES; RISK;

EID: 84886417733     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25587     Document Type: Article

References (35)

1. Blin O, Ferrandez AM, Serratrice G. Quantitative analysis of gait in Parkinson patients: increased variability of stride length. J Neurol Sci 1990;98:91-97.
2. Hausdorff JM, Cudkowicz ME, Firtion R, et al. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease. Mov Disord 1998;13:428-437.
3. Baltadjieva R, Giladi N, Gruendlinger L, et al. Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease. Eur J Neurosci 2006;24:1815-1820.
4. Carpinella I, Crenna P, Calabrese E, et al. Locomotor function in the early stage of Parkinson's disease. IEEE Trans Neural Syst Rehabil Eng 2007;15:543-551.
5. Kachergus J, Mata IF, Hulihan M, et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 2005;76:672-680.
6. Ozelius LJ, Senthil G, Saunders-Pullman R, et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 2006;354:424-425.
7. Thaler A, Ash E, Gan-Or Z, et al. The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews. J Neural Transm 2009;116:1473-1482.
8. Healy DG, Falchi M, O'Sullivan SS, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 2008;7:583-590.
9. Marras C, Schule B, Munhoz RP, et al. Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology 2011;77:325-333.
10. Alcalay RN, Mejia-Santana H, Tang MX, et al. Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Arch Neurol 2009;66:1517-1522.
11. Mirelman A, Gurevich T, Giladi N, et al. Gait alterations in healthy carriers of the LRRK2 G2019S mutation. Ann Neurol 2011;69:193-197.
12. Thaler A, Mirelman A, Gurevich T, et al. Lower cognitive performance in healthy G2019S LRRK2 mutation carriers. Neurology 2012;79:1027-1032.
13. Fahn S, Elton RL, Members of the UPDRS Development Committee. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldsetin M, editors. Recent Developments in Parkinson's Disease, vol 2. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-163.
14. Podsiadlo D, Richardson S. The timed "up & go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142-148.
15. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982;17:37-49.
16. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-699.
17. Stuss DT, Bisschop SM, Alexander MP, et al. The Trail Making Test: a study in focal lesion patients. Psychol Assess 2001;13:230-239.
18. Hsieh YH, Chen KJ, Wang CC, et al. Cognitive and motor components of response speed in the Stroop test in Parkinson's disease patients. Kaohsiung J Med Sci 2008;24:197-203.
19. Verghese J, Holtzer R, Lipton RB, et al. Quantitative gait markers and incident fall risk in older adults. J Gerontol A Biol Sci Med Sci 2009;64:896-901.
20. Hausdorff JM. Stride variability: beyond length and frequency [letter]. Gait Posture 2004;20:304.
21. Yogev G, Giladi N, Peretz C, et al. Dual tasking, gait rhythmicity, and Parkinson's disease: which aspects of gait are attention demanding? Eur J Neurosci 2005;22:1248-1256.
22. Hausdorff JM. Gait dynamics in Parkinson's disease: common and distinct behavior among stride length, gait variability, and fractal-like scaling [serial online]. Chaos 2009;19:026113.
23. Moe-Nilssen R, Helbostad JL. Estimation of gait cycle characteristics by trunk accelerometry. J Biomech 2004;37:121-126.
24. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990;40:1529-1534.
25. Orr-Urtreger A, Shifrin C, Rozovski U, et al. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Neurology 2007;69:1595-1602.
26. Gan-Or Z, Bar-Shira A, Mirelman A, et al. LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease. Neurogenetics 2010;11:121-125.
27. Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and attention in gait. Mov Disord 2008;23:329-342.
28. Burn DJ, Rowan EN, Allan LM, et al. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006;77:585-589.
29. Kristensen MT, Foss NB, Kehlet H. Timed "up & go" test as a predictor of falls within 6 months after hip fracture surgery. Phys Ther 2007;87:24-30.
30. Herman T, Giladi N, Hausdorff JM. Properties of the "Timed Up and Go" test: more than meets the eye. Gerontology 2011;57:203-210.
31. Alves G, Larsen JP, Emre M, et al. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord 2006;21:1123-1130.
32. Peretz C, Korczyn AD, Shatil E, et al. Computer-based, personalized cognitive training versus classical computer games: a randomized double-blind prospective trial of cognitive stimulation. Neuroepidemiology 2011;36:91-99.
33. Yogev-Seligmann G, Giladi N, Brozgol M, et al. A training program to improve gait while dual tasking in patients with Parkinson's disease: a pilot study. Arch Phys Med Rehabil 2012;93:176-181.
34. Mirelman A, Maidan I, Herman T, Deutsche JE, Giladi N, Hausdorff JM. Virtual reality for gait training: can it induce motor learning to enhance complex walking and reduce fall risk in patients with Parkinson's disease? J Gerontol A Biol Sci Med Sci 2011;66:234-240.
35. Nieuwboer A, Kwakkel G, Rochester L, et al. Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry 2007;78:134-140.